iiinova — where your digital self keeps evolving

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 03/03/2026

New in JASN: CARE shows a hybrid path to equitable APOL1-kidney disease (AMKD) screening + trial pipelines—community partnerships = reach, EHR/MD referrals = yield. journals.lww.com/jasn/pages/a... #Nephrology #KidneyDisease #APOL1 #AMKD #HealthEquity #ClinicalTrials #PrecisionMedicine #JASN

020

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 18/08/2025

It was a pleasure to have Dr. Sanna-Cherchi @genetickidneydoc.bsky.social give an excellent, well-attended, Renal Grand Rounds at @dukekidney.bsky.social He is an embodiment of collaborative excellence💪🏾 @columbiakidney.bsky.social

020

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 20/07/2025

I wasn’t born into wealth. I was born into the strength of Joshua Olabisi. His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns. Read it here: www.amazon.com/Twice-Immigr... #Legacy #Resilience #TwiceASurvivor My father’s story. My lifelong inspiration.

amazon.com

Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped

Amazon.com: Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped: 9798287609443: Olabisi, Joshua, Onime, Godfrey: Books

020

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 16/05/2025

I am delighted to step into this exciting role. I look forward to advancing the clinical, research and educational missions of Duke Nephrology while supporting colleagues and inspiring learners!

071

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 22/03/2025

Simone @genetickidneydoc.bsky.social is a visionary and alliance-building, result-oriented scientist. His #rFSGS biobank will help the whole community. Refer your rFSGS patients to his registry. Together, we can conquer the #rFSGS menace.

120

Reposted by Opeyemi Olabisi

Simone Sanna-Cherchi 🧬 @genetickidneydoc.bsky.social · 18/03/2025

Our #rFSGS biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures. #KidneyMonth2025 #RareDisease #genetics

0125

Reposted by Opeyemi Olabisi

Duke Kidney @dukekidney.bsky.social · 16/02/2025

Congratulations to Dr. Tomasi @AleTomasiMD on being appointed as the chief nephrology fellow for the academic year 2025-2026.

082

Reposted by Opeyemi Olabisi

Duke Kidney @dukekidney.bsky.social · 15/02/2025

New from Dr Anika Lucas and colleagues in Kidney360 2nd Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus journals.lww.com/kid...

032

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 26/01/2025

Face-to-face interactions often facilitate collaboration and innovation. Therefore, @dukekidney.bsky.social research retreat focused on ways to increase purposeful interaction and collaboration. It was a time well spent!

131

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 10/01/2025

I am delighted to be elected as a member of The American Society for Clinical Investigation! I’m thankful for my dedicated lab team, mentors, supportive family & colleagues @the-asci.bsky.social @dukekidney.bsky.social @dukemedschool.bsky.social

5121

Reposted by Opeyemi Olabisi

Krista Lentine, MD,PhD @kristalentine.bsky.social · 06/01/2025

😁 Delighted to have my copy of ‘The Body’s Keepers’📔personally signed by author, Dr. Paul Kimmel🖋️ . This📔offers both a historical perspective➕personal look at development of kidney failure treatments, highlighting advances along w/ ongoing challenges | #KidneyHealth | #Innovation 🏥 👉🏽 t.ly/7UuYT

151

Reposted by Opeyemi Olabisi

Paul A. Welling, MD @pawellingmd.bsky.social · 01/01/2025

Summer Undergraduate Program in Kidney Science (SUPerKS) provides talented students the unique opportunity to explore research and physician-scientist careers in the kidney field with exposure to the practice of medicine. hopkinsmedicine.org/nephrology/e... Applications due by February 1, 2025

hopkinsmedicine.org

Summer Undergraduate Program in Kidney Science (SUPerKS)

076

Reposted by Opeyemi Olabisi

Katalin Susztak @ksusztak.bsky.social · 18/12/2024

JCI - Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice www.jci.org/articles/vie...

jci.org

JCI - Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice

072

Reposted by Opeyemi Olabisi

Duke OPSD PRIME @duke-opsd-prime.bsky.social · 19/12/2024

We featured Chideraa Emma-Ugwuoke an outstanding PRIME PUMP scholar in the Student Corner of the OPSD December Newsletter. He worked with @opeyemiolabisi.bsky.social. Click the link to learn more about Chideraa's summer research experience @dukemedschool.bsky.social. mailchi.mp/duke/opsd-de...

012

Reposted by Opeyemi Olabisi

Kidney International @kidneyint.bsky.social · 12/12/2024

Hello there, #NephSky 🙂 Check out the December issue of KI! Topics include: 🔹#AKI after hair straightening 🔹RAS inhibition attenuates #FSGS in mice with #APOL1 risk variants 🔹A dual #GLP-1 and glucagon receptor agonist in #diabetickidneydisease 🔗doi.org/10.1016/j.kint.2024.10.006 #MedSky

2147

Reposted by Opeyemi Olabisi

Simone Sanna-Cherchi 🧬 @genetickidneydoc.bsky.social · 11/12/2024

How did the #APOL1 protective variant arise on the G2 haplotype? My initial guess was by independent mutational event, but look at this: a close proximity recombination event between G0 and G2. Read this report from Martin Pollak team to which we contributed #FSGS academic.oup.com/g3journal/ad...

academic.oup.com

The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event

Abstract. Black Americans are three to four times more likely to develop nondiabetic kidney disease than other populations. Exclusively found in people of

073

Reposted by Opeyemi Olabisi

Simone Sanna-Cherchi 🧬 @genetickidneydoc.bsky.social · 29/11/2024

Minus 10 days to the first ever, recurrent FSGS Conference! Registration is open for a few more days! Meet in person >60 patients/family members, Congressmen and Senators, and top scientists! ⬇️ @gbadegesinlab.bsky.social @kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social #rFSGS #nephsky

173

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 29/11/2024

@genetickidneydoc.bsky.social it was delightful working with you and your excellent team on this perspective.

061

Reposted by Opeyemi Olabisi

gbadegesinlab.bsky.social @gbadegesinlab.bsky.social · 23/11/2024

The final version of our paper www.nejm.org/doi/10.1056/... One APOL1 risk variant is associated with CKD & FSGS. We have a solid basis for new mechanistic studies in our journey to find durable cure for APOL1 KD @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social @genetickidneydoc.bsky.social

24415

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 22/11/2024

Are your patients with APOL1 kidney disease on optimal doses of ACEi/ARB? See my new commentary on an interesting mouse-based study from Pollak lab #APOL1 @genetickidneydoc.bsky.social @nephrosparks.bsky.social @kidneyomicsamps.bsky.social @gbadegesinlab.bsky.social @dukekidney.bsky.social

0145

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 22/11/2024

I look forward to participating in this important conference!

020

Reposted by Opeyemi Olabisi

gbadegesinlab.bsky.social @gbadegesinlab.bsky.social · 22/11/2024

rFSGS is a major cause of kidney tx loss. There is a need for multidisciplinary rethinking of how we are going to solve this. We are all looking forward to the Dec 9th meeting in DC @genetickidneydoc.bsky.social @isgd.bsky.social #ASPN @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social

042

Opeyemi Olabisi @opeyemiolabisi.bsky.social · 21/11/2024

Coming from X to Bsky and reconnecting with friends and colleagues who also fled the toxicity feels like post-apocalypse. You made it out of the cave/bunker and discovered that many of your loved ones also made it🤓

020